Zacks Investment Research It has been about a month since the last earnings report for Madrigal (MDGL). Shares have added about 1% in that time frame, underperforming the S&P 500.Will the recent positive trend continue...\n more…
Ticker Report Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH - Get Free Report) have been given a consensus recommendation of "Hold" by the five ratings firms that are covering the stock, MarketBeat Ratings...\n more…
Ticker Report Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Zacks Research lowered their Q3 2024 EPS estimates for shares of Theravance Biopharma in a report issued on Monday, August 26th. Zacks...\n more…
Ticker Report Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Analysts at Zacks Research boosted their Q4 2025 earnings per share estimates for Theravance Biopharma in a research report issued on Monday...\n more…
PR Newswire Theravance Biopharma to Participate in an Upcoming Investor Conference Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire DUBLIN, Aug. 27, 2024 DUBLIN, Aug. 27, 2024...\n more…
Ticker Report California State Teachers Retirement System lowered its position in Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) by 17.1% in the first quarter, according to its most recent Form 13F filing...\n more…